Daiwa Securities Group
SLDB icon

Daiwa Securities Group’s Solid Biosciences SLDB Stock Holding History

Daiwa Securities Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-231
Closed -$1K – 1404
2025
Q4 		$1K Sell
231
-169
-42% -$916 ﹤0.01% 1354
2025
Q3 		$2K Hold
400
– – ﹤0.01% 1285
2025
Q2 		$2K Hold
400
– – ﹤0.01% 1227
2025
Q1 		$1K Buy
+400
New +$1.71K ﹤0.01% 1252
2020
Q4 		– Sell
-20
Closed -$1K – 1297
2020
Q3 		$1K Hold
20
– – ﹤0.01% 1168
2020
Q2 		$1K Hold
20
– – ﹤0.01% 1194
2020
Q1 		$1K Hold
20
– – ﹤0.01% 1198
2019
Q4 		$1K Hold
20
– – ﹤0.01% 1189
2019
Q3 		$3K Hold
20
– – ﹤0.01% 1107
2019
Q2 		$2K Hold
20
– – ﹤0.01% 1153
2019
Q1 		$3K Hold
20
– – ﹤0.01% 1113
2018
Q4 		$8K Buy
+20
New +$9.4K ﹤0.01% 1014

Other funds holding SLDB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Daiwa Securities Group's SLDB Position: Q1 2026 in Review

Daiwa Securities Group sold out of Solid Biosciences (SLDB) in Q1 2026, closing a stake of 231 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in SLDB in Q4 2018 and held it in 12 quarters. The position peaked at $8K in Q4 2018. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Daiwa Securities Group reported no remaining Solid Biosciences position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 231 Solid Biosciences shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Solid Biosciences in Q4 2018 and held it in 12 quarters.
  • Daiwa Securities Group's Solid Biosciences position peaked at $8K in Q4 2018.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.